尿道狭窄治療装置の世界市場：洞察、競合情勢、市場予測：2030年

世界の尿道狭窄治療装置の市場規模は、2020年に14億8,000万米ドルとなりました。同市場は、2024年から2030年までの予測期間中に7.10％ので拡大し、2030年には22億3,000万米ドルに達すると予測されています。尿道狭窄治療装置の需要が急増している主な理由は、大腸がんや前立腺がんなどの骨盤領域におけるがんの有病率の上昇であり、がん治療が尿道狭窄形成の確率の上昇と関連していること、前立腺肥大症の有病率の上昇、外科的介入の合併症として尿道狭窄が形成される可能性があることなどが挙げられる、加齢が尿道カテーテルの多用に起因する尿道狭窄の発症につながる神経因性膀胱など数多くの疾患の発症に主要な役割を果たす高齢者人口の増加、および薬剤溶出性泌尿器バルーンなどの製品開発の進歩が、予測期間中の尿道狭窄治療装置市場の成長を後押ししています。

尿道狭窄治療装置市場は、大腸がんや前立腺がんなど、骨盤領域に特化した様々ながんの有病率が上昇していることを理由の1つとして、製品需要の急増を観察しています。世界保健機関（WHO）のデータによると、2020年、結腸・直腸がんは世界で3番目に多いがんであり、193万人が新たに罹患しました。WHOによる同じファクトシートでは、2020年、前立腺がんは世界で4番目に多いがん種であり、141万人の新規症例を占めています。尿道狭窄は、前立腺がんや直腸がんの放射線治療、前立腺肥大や前立腺がんの手術、性器や会陰部の外傷の合併症として関連しています。がん治療、特に前立腺がんに対する放射線療法では、治療部位周辺の血管が減少することがさまざまな研究で立証されています。さらに、ブラキセラピーと外部照射療法の両方を受けた患者では、尿道狭窄を発症するリスクがさらに高まるようです。さらに、放射状前立腺摘除術も尿道狭窄の形成の可能性を有意に増加させることが報告されており、骨盤領域のがんの治療が尿道狭窄の形成につながる可能性があることを示しています。したがって、骨盤領域におけるがんの有病率の増加は、尿道狭窄の発生率の増加をもたらし、ひいては尿道狭窄治療装置の需要を促進し、最終的に予測期間中の尿道狭窄治療装置市場を牽引する可能性があります。

当レポートでは、世界の尿道狭窄治療装置市場について調査し、市場の概要とともに、製品タイプ別、狭窄位置別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 尿道狭窄治療装置市場レポートのイントロダクション

第2章 尿道狭窄治療装置市場のエグゼクティブサマリー

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 尿道狭窄治療装置市場の主な要因分析

• 尿道狭窄治療装置市場の促進要因
• 尿道狭窄治療装置市場の抑制要因と課題
• 尿道狭窄治療装置市場の機会

第5章 尿道狭窄治療装置市場におけるポーターのファイブフォース分析

第6章 尿道狭窄治療装置市場に対するCOVID-19の影響分析

第7章 尿道狭窄治療装置の市場概要

• 製品タイプ別
• 狭窄位置別
• エンドユーザー別
• 地域別

第8章 尿道狭窄治療装置市場における企業と製品プロファイル

• Boston Scientific Corporation
• Laborie
• Cook
• Teleflex Incorporated
• B. Braun Melsungen AG
• Allium Ltd
• Pnn Medical A/S
• Zhejiang ChuangXiang Medical Technology co., LTH
• UROMED Kurt Drews KG
• Med pro Medical B.V.
• BD
• Coloplast
• Med pro Medical B.V.
• ConvaTec Inc
• BACTIGUARD AB

第9章 KOL の見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: COVID-19 Impact Analysis on Urethral Stricture Treatment Devices Market
• Table 3: Urethral Stricture Treatment Devices Market in Global (2021-2030)
• Table 4: Urethral Stricture Treatment Devices Market in Global by Product Type (2021-2030)
• Table 5: Urethral Stricture Treatment Devices Market in Global by Stricture Location (2021-2030)
• Table 6: Urethral Stricture Treatment Devices Market in Global by End User (2021-2030)
• Table 7: Urethral Stricture Treatment Devices Market in Global by Geography (2021-2030)
• Table 8: Urethral Stricture Treatment Devices Market in North America (2021-2030)
• Table 9: Urethral Stricture Treatment Devices Market in North America by Country (2021-2030)
• Table 10: Urethral Stricture Treatment Devices Market in the US (2021-2030)
• Table 11: Urethral Stricture Treatment Devices Market in Canada (2021-2030)
• Table 12: Urethral Stricture Treatment Devices Market in Mexico (2021-2030)
• Table 13: Urethral Stricture Treatment Devices Market in Europe (2021-2030)
• Table 14: Urethral Stricture Treatment Devices Market in Europe by Country (2021-2030)
• Table 15: Urethral Stricture Treatment Devices Market in France (2021-2030)
• Table 16: Urethral Stricture Treatment Devices Market in Germany (2021-2030)
• Table 17: Urethral Stricture Treatment Devices Market in the United Kingdom (2021-2030)
• Table 18: Urethral Stricture Treatment Devices Market in Italy (2021-2030)
• Table 19: Urethral Stricture Treatment Devices Market in Spain (2021-2030)
• Table 20: Urethral Stricture Treatment Devices Market in Russia (2021-2030)
• Table 21: Urethral Stricture Treatment Devices Market in Rest of Europe (2021-2030)
• Table 22: Urethral Stricture Treatment Devices Market in APAC (2021-2030)
• Table 23: Urethral Stricture Treatment Devices Market in APAC by Country (2021-2030)
• Table 24: Urethral Stricture Treatment Devices Market in China (2021-2030)
• Table 25: Urethral Stricture Treatment Devices Market in Japan (2021-2030)
• Table 26: Urethral Stricture Treatment Devices Market in India (2021-2030)
• Table 27: Urethral Stricture Treatment Devices Market in Australia (2021-2030)
• Table 28: Urethral Stricture Treatment Devices Market in South Korea (2021-2030)
• Table 29: Urethral Stricture Treatment Devices Market in Rest of APAC (2021-2030)
• Table 30: Urethral Stricture Treatment Devices Market in Rest of World (2021-2030)
• Table 31: Urethral Stricture Treatment Devices Market in RoW by Region (2021-2030)
• Table 32: Urethral Stricture Treatment Devices Market in Middle East (2021-2030)
• Table 33: Urethral Stricture Treatment Devices Market in Africa (2021-2030)
• Table 34: Urethral Stricture Treatment Devices Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: COVID-19 Impact Analysis on Urethral Stricture Treatment Devices Market
• Figure 3: Urethral Stricture Treatment Devices Market in Global (2021-2030)
• Figure 4: Urethral Stricture Treatment Devices Market in Global by Product Type (2021-2030)
• Figure 5: Urethral Stricture Treatment Devices Market in Global by Stricture Location (2021-2030)
• Figure 6: Urethral Stricture Treatment Devices Market in Global by End User (2021-2030)
• Figure 7: Urethral Stricture Treatment Devices Market in Global by Geography (2021-2030)
• Figure 8: Urethral Stricture Treatment Devices Market in North America (2021-2030)
• Figure 9: Urethral Stricture Treatment Devices Market in North America by Country (2021-2030)
• Figure 10: Urethral Stricture Treatment Devices Market in the US (2021-2030)
• Figure 11: Urethral Stricture Treatment Devices Market in Canada (2021-2030)
• Figure 12: Urethral Stricture Treatment Devices Market in Mexico (2021-2030)
• Figure 13: Urethral Stricture Treatment Devices Market in Europe (2021-2030)
• Figure 14: Urethral Stricture Treatment Devices Market in Europe by Country (2021-2030)
• Figure 15: Urethral Stricture Treatment Devices Market in France (2021-2030)
• Figure 16: Urethral Stricture Treatment Devices Market in Germany (2021-2030)
• Figure 17: Urethral Stricture Treatment Devices Market in the United Kingdom (2021-2030)
• Figure 18: Urethral Stricture Treatment Devices Market in Italy (2021-2030)
• Figure 19: Urethral Stricture Treatment Devices Market in Spain (2021-2030)
• Figure 20: Urethral Stricture Treatment Devices Market in Russia (2021-2030)
• Figure 21: Urethral Stricture Treatment Devices Market in Rest of Europe (2021-2030)
• Figure 22: Urethral Stricture Treatment Devices Market in APAC (2021-2030)
• Figure 23: Urethral Stricture Treatment Devices Market in APAC by Country (2021-2030)
• Figure 24: Urethral Stricture Treatment Devices Market in China (2021-2030)
• Figure 25: Urethral Stricture Treatment Devices Market in Japan (2021-2030)
• Figure 26: Urethral Stricture Treatment Devices Market in India (2021-2030)
• Figure 27: Urethral Stricture Treatment Devices Market in Australia (2021-2030)
• Figure 28: Urethral Stricture Treatment Devices Market in South Korea (2021-2030)
• Figure 29: Urethral Stricture Treatment Devices Market in Rest of APAC (2021-2030)
• Figure 30: Urethral Stricture Treatment Devices Market in Rest of World (2021-2030)
• Figure 31: Urethral Stricture Treatment Devices Market in RoW by Region (2021-2030)
• Figure 32: Urethral Stricture Treatment Devices Market in Middle East (2021-2030)
• Figure 33: Urethral Stricture Treatment Devices Market in Africa (2021-2030)
• Figure 34: Urethral Stricture Treatment Devices Market in South America (2021-2030)
• Figure 35: Market Drivers
• Figure 36: Market Barriers
• Figure 37: Marker Opportunities
• Figure 38: PORTER'S Five Force Analysis

Urethral Stricture Treatment Devices Market By Product Type (Urethral Dilators, Urethral Stents, Urethral Balloon Dilation Catheters, And Urinary Catheters), By Stricture Location (Anterior And Posterior), By End User (Hospitals, Specialty Clinics, And Others), and by geography is expected to grow at a steady CAGR (forecast period- 2024-2030) owing to increase in probability of urethral stricture formation as a complication of cancer treatment for prostate and colorectal cancers as well as extensive use of urinary catheters

Global urethral stricture treatment devices market was valued at USD 1.48 billion in 2020, growing at a CAGR of 7.10% during the forecast period from 2024 to 2030 to reach USD 2.23 billion by 2030. The demand for urethral stricture treatment devices is witnessing a surge majorly due to the rising prevalence of cancers in the pelvic region such as colorectal and prostate cancers wherein the cancer treatment is linked with increased probability of urethral stricture formation, growing prevalence of benign prostatic hyperplasia in which urethral stricture may form as a complication of surgical interventions, increasing geriatric population wherein aging plays a major role in the development of numerous diseases such as neurogenic bladder leading to the development of urethral strictures sue to extensive use of urinary catheters, and advancements in product development such as drug-eluting urology balloon thereby boosting the growth of the urethral stricture treatment devices market during the forecast period.

Urethral Stricture Treatment Devices Market Dynamics:

The urethral stricture treatment devices market is observing a surge in product demand due to plethora of reasons with one of them being the rising prevalence of various cancers specifically in the pelvic region such as colorectal and prostate cancers. As per the data cited by the World Health Organization (WHO), in 2020, cancer of the colon and rectum were the third-most common cancer type globally and accounted for 1.93 million new cases. In the same factsheet by the WHO, in 2020, prostate cancer was the fourth-most prevalent cancer type globally and accounted for 1.41 million new cases. Urethral strictures have been associated as a complication of radiation treatment for prostate and rectal cancers, surgery for an enlarged prostate or prostate cancer, or trauma to the genitals or perineum. It has been established in various studies that radiation therapy for cancer treatment, particularly prostate cancer, leads to reduced vascularity around the treatment area. Furthermore, the risk for developing urethral strictures appear to enhance further in patient receiving both the brachytherapy and external beam radiation therapy. Additionally, it has also been reported that radial prostatectomy also significantly increases the chances of the formation of urethral strictures thereby indicating that treatment of cancers in the pelvic region may result in the formation of urethral strictures. Therefore, the rising prevalence of cancers in the pelvic region may result in the increased incidence of urethral strictures which in turn may drive the demand for urethral strictures treatment devices ultimately driving the urethral strictures treatment devices market during the forecast period.

Another important aspect driving the demand for urethral stricture treatment devices market is the rising geriatric population. As per the statistics quoted by the World Health Organization in their Decade of Healthy Ageing (2020-2030) Report, it has been estimated that people in the age bracket of 60 years and older will account for 34% more share in the total population, increasing from one billion in 2019 to 1.4 billion by 2030. The report further mentioned that by 2050, the global elderly population is expected to reach 2.1 billion. Aging is considered as one of the key risk factors that heavily contributes in the development of various indications such as benign prostatic hyperplasia (BPH), neurogenic bladder among other indications. BPH is most commonly treated by simple prostatectomies and transurethral resection of the prostate wherein urethral strictures are reported as a common complication. Furthermore, the increasing prevalence of neurogenic bladder also results in the increased chances of urethral stricture formation due to trauma or injury caused with the extensive use of urinary catheters. Therefore, the rising geriatric population is expected to result in increasing prevalence of diseases such as BPH where the treatment may result in the formation of urethral strictures, thereby bolstering the growth of the urethral stricture treatment devices in coming years.

However, device-related complications and the availability of alternative surgical approaches such as urethroplasty may be limiting factors for the growth of the urethral stricture treatment devices market.

Besides the above-mentioned factors, the urethral stricture treatment devices market registered a period of decline in revenue generation due to the COVID-19 pandemic. The lockdown implemented by various governments worldwide to contain the spread of the COVID-19 infection resulted in postponement of outpatient consultations and various surgeries across all medical specialties specifically impacting elective procedures. This led to a considerable reduction in the demand for urethral stricture treatment procedures were classified under non-emergency procedures. Furthermore, the implementation of global lockdown in also impacted the procurement and supply chain. Although, the regulatory approval of various COVID-19 vaccines and mass vaccination programs have been crucial in reestablishing the demand for urethral stricture treatment devices, thereby presenting a positive growth environment for the urethral stricture treatment devices market during the forecast period.

Urethral Stricture Treatment Devices Market Segment Analysis:

Urethral Stricture Treatment Devices Market by Product Type (Urethral Dilators, Urethral Stents, Urethral Balloon Dilation Catheters, and Urinary Catheters), by Stricture Location (Anterior and Posterior), by End User (Hospitals, Specialty Clinics, and Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product segment of the urethral stricture treatment devices market, the urethral balloon dilation catheters category is expected to register a healthy CAGR in the urethral stricture treatment devices market during the forecast period. This can be attributed to the advantages offered by these devices over their counterparts. Balloon dilation is a well-tolerated, safe, office-based procedure that offers multiple advantages over sequential rigid dilation and internal urethrotomy. It is associated with minimal complications. Furthermore, urethral balloon dilation is considered as a minimally invasive technique that has the potential advantage of being less morbid and is technically less challenging to perform. It is also considered to be less traumatic than sequential rigid dilatation.

Owing to the advantages associated with the urethral balloon dilation catheters, there have been an increase in the development of newer products aimed at treating urethral strictures. For instance, in December 2022, Urotronic received the regulatory approval from the US Food and Drug Administration for their product- Optilume, durg-coated urology balloon, which elutes a highly lipophilic drug, paclitaxel that limits hyperactive cell proliferation and the fibrotic scar tissue generation that results in stricture recurrence.

Therefore, the advantages associated with urethral balloon dilation and the innovation in product development are expected to boost the demand for this product category thereby ultimately propelling the market for urethral balloon dilation catheters during the forecast period.

North America is expected to dominate the overall Urethral Stricture Treatment Devices Market:

Among all the regions, North America is estimated to account for the largest share in the urethral stricture treatment devices market. This domination is due to the increase in prevalence of sexually transmitted diseases, increasing prevalence of cancers in the region. Furthermore, the rising geriatric population as well as growing cases of obesity in the US population are also expected to result in growing number of urethral strictures in the North American region. Additionally, extensive research and development activities pertaining to product development and conducive regulatory environment further helps product manufacturers to generate more revenue from the region.

One of the key driving factors of the United States urethral stricture treatment devices market is the interplay of various factors in the country. For instance, as per the data cited by the Centers for Disease Control and Prevention (2023), in 2019, 2.6 million cases of sexually transmitted diseases were reported in the country registering a 6th-consecutive year increase from 1.4 million in 2014. STDs like gonorrhea are reported to cause infection and inflammation in the urethra, leading to scarring and stricture. Some chronic inflammatory skin conditions like lichen sclerosus can also cause urethral strictures. Therefore, the presence of large patient population suffering from sexually transmitted diseases correlates to the presence of a potential patient population that may resort to using urethral stricture devices as a treatment method, thus driving the product demand in the nation.

Moreover, increasing obese population is also expected to drive the demand for urethral stricture treatment devices in the country. For instance, as per the data provided by the CDC (2023), in 2017-2018, the obesity prevalence in the country was 42.4%. Obesity has been associated with increased mean urethral stricture length in obese patients compared to patients with a normal body-mass index.

Thus, the interplay of all the aforementioned factors are likely to fuel the market growth of urethral stricture treatment devices in the United States during the forecast period.

Urethral Stricture Treatment Devices Market Key Players:

Some of the key market players operating in the urethral stricture treatment devices market includes Boston Scientific Corporation, Laborie, Cook, Teleflex Incorporated, B. Braun Melsungen AG, Allium Ltd., Pnn Medical A/S, Zhejiang ChuangXiang Medical Technology co., LTH, UROMED Kurt Drews KG, Med pro Medical B.V., BD, Cardinal Health. Coloplast, ConvaTec Inc, BACTIGUARD AB and others.

Recent Developmental Activities in Urethral Stricture Treatment Devices Market:

In December 2022, Urotronic received the regulatory approval from the US Food and Drug Administration for their product- Optilume, durg-coated urology balloon, which elutes a highly lipophilic drug, paclitaxel that limits hyperactive cell proliferation and the fibrotic scar tissue generation that results in stricture recurrence.

Key Takeaways from the Urethral Stricture Treatment Devices Market Report Study

Market size analysis for current urethral stricture treatment devices market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the urethral stricture treatment devices market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the global urethral stricture treatment devices market.

Various opportunities available for the other competitor in the urethral stricture treatment devices market space.

What are the top performing segments in 2023? How these segments will perform in 2030.

Which is the top-performing regions and countries in the current urethral stricture treatment devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for urethral stricture treatment devices market growth in the coming future?

Target Audience who can be benefited from this Urethral Stricture Treatment Devices Market Report Study

Urethral stricture treatment devices products providers

Research organizations and consulting companies

Urethral stricture treatment device-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in urethral stricture treatment devices

Various End-users who want to know more about the urethral stricture treatment devices market and latest technological developments in the urethral stricture treatment devices market.

Frequently Asked Questions for Urethral Stricture Treatment Devices Market:

1. What is a Urethral Stricture Treatment Device?

A urethral stricture treatment device is a medical device which helps in treating the narrowing of the urethra by opening it up and helping in passage of urine. Urethral dilators, urology balloons, and urethral stents among other interventions.

2. What is the market for Global Urethral Stricture Treatment Devices?

Global urethral stricture treatment devices market was valued at USD 1.48 billion in 2020, growing at a CAGR of 7.10% during the forecast period from 2024 to 2030 to reach USD 2.23 billion by 2030.

3. What are the drivers for Global Urethral Stricture Treatment Devices Market?

The demand for urethral stricture treatment devices is witnessing a surge majorly due to the rising prevalence of cancers in the pelvic region such as colorectal and prostate cancers wherein the cancer treatment is linked with increased probability of urethral stricture formation, growing prevalence of benign prostatic hyperplasia in which urethral stricture may form as a complication of surgical interventions, increasing geriatric population wherein aging plays a major role in the development of numerous diseases such as neurogenic bladder leading to the development of urethral strictures sue to extensive use of urinary catheters, and advancements in product development such as drug-eluting urology balloon thereby boosting the growth of the urethral stricture treatment devices market during the forecast period.

4. Who are the key players operating in Global Urethral Stricture Treatment Devices Market?

Some of the key market players operating in the urethral stricture treatment devices market includes Boston Scientific Corporation, Laborie, Cook, Teleflex Incorporated, B. Braun Melsungen AG, Allium Ltd., Pnn Medical A/S, Zhejiang ChuangXiang Medical Technology co., LTH, UROMED Kurt Drews KG, Med pro Medical B.V., BD, Cardinal Health. Coloplast, ConvaTec Inc, BACTIGUARD AB and others.

5. Which region has the highest share in Urethral Stricture Treatment Devices market?

Among all the regions, North America is estimated to account for the largest share in the urethral stricture treatment devices market. This domination is due to the increase in prevalence of sexually transmitted diseases, increasing prevalence of cancers in the region. Furthermore, the rising geriatric population as well as growing cases of obesity in the US population are also expected to result in growing number of urethral strictures in the North American region. Additionally, extensive research and development activities pertaining to product development and conducive regulatory environment further helps product manufacturers to generate more revenue from the region.

Table of Contents

1.Urethral Stricture Treatment Devices Market Report Introduction

2.Urethral Stricture Treatment Devices Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment
• 2.4. Financial Benchmarking

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Urethral Stricture Treatment Devices Market Key Factors Analysis

• 4.1. Urethral Stricture Treatment Devices Market Drivers
  • 4.1.1. Rising Prevalence of Cancers in the Pelvic Region
  • 4.1.2. Increasing Cases of Benign Prostatic Hyperplasia
  • 4.1.3. Growing Geriatric Population Base
  • 4.1.4. Technological Advancements in Product Development
• 4.2. Urethral Stricture Treatment Devices Market Restraints and Challenges
  • 4.2.1. Device-Related Complications
  • 4.2.2. Availability of Alternative Surgical Approaches such as Urethroplasty
• 4.3. Urethral Stricture Treatment Devices Market Opportunities
  • 4.3.1. Improving on the Product Design
  • 4.3.2. Targeting Emerging Markets for Product Launches

5. Urethral Stricture Treatment Devices Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Urethral Stricture Treatment Devices Market

7. Urethral Stricture Treatment Devices Market Layout

• 7.1. By Product Type
  • 7.1.1. Urethral Dilators
  • 7.1.2. Urethral Stents
  • 7.1.3. Urethral Balloon Dilation Catheters
  • 7.1.4. Urinary Catheters
• 7.2. By Stricture Location
  • 7.2.1. Anterior
  • 7.2.2. Posterior
• 7.3. By End User
  • 7.3.1. Hospitals
  • 7.3.2. Specialty Clinics
  • 7.3.3. Others
• 7.4. By Geography
  • 7.4.1. North America
    • 7.4.1.1. North America Urethral Stricture Treatment Devices Market, by Country
    • 7.4.1.4.1. United States
    • 7.4.1.4.2. Canada
    • 7.4.1.4.3. Mexico
  • 7.4.2. Europe
    • 7.4.2.1. Europe Urethral Stricture Treatment Devices Market, by Country
    • 7.4.2.4.1. France
    • 7.4.2.4.2. Germany
    • 7.4.2.4.3. United Kingdom
    • 7.4.2.4.4. Italy
    • 7.4.2.4.5. Spain
    • 7.4.2.2.6. Russia
    • 7.4.2.2.7. Rest of Europe
  • 7.4.3. Asia-Pacific
    • 7.4.3.1. Asia-Pacific Urethral Stricture Treatment Devices Market, by Country
    • 7.4.3.4.1. China
    • 7.4.3.4.2. Japan
    • 7.4.3.4.3. India
    • 7.4.3.4.4. Australia
    • 7.4.3.4.5. South Korea
    • 7.4.3.4.6. Rest of Asia Pacific
  • 7.4.4. Rest of the World (RoW)
    • 7.4.4.1. RoW Urethral Stricture Treatment Devices Market, by Region
    • 7.4.4.4.1. Middle East
    • 7.4.4.4.2. Africa
    • 7.4.4.4.3. South America

8. Urethral Stricture Treatment Devices Market Company and Product Profiles

• 8.1. Boston Scientific Corporation
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. Laborie
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. Cook
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. Teleflex Incorporated
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. B. Braun Melsungen AG
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. Allium Ltd
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. Pnn Medical A/S
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. Zhejiang ChuangXiang Medical Technology co., LTH
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. UROMED Kurt Drews KG
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. Med pro Medical B.V.
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. BD
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. Coloplast
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. Med pro Medical B.V.
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. ConvaTec Inc
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. BACTIGUARD AB
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us